May 2026: Wegovy HD Goes Nationwide, Foundayo Hits Telehealth, and FDA Moves to Permanently Ban Compounded GLP-1s
April delivered the biggest GLP-1 catalyst in years — Wegovy HD launched nationwide, Lilly's Foundayo pill hit pharmacies and telehealth, Medicare Zepbound coverage went live, and the FDA proposed a permanent ban on mass compounding of semaglutide and tirzepatide. Here's what changed and what it means for your provider choice.